New hope in the face of triple-negative breast cancerResults of McGill study could make it possible to target and personalize treatments for patients with this kind of breast cancer or with other solid tumours. Cancer research blasts off: Materials behave differently in lower gravity allowing for accelerated researchApparently space is the place, specifically the International Space Station, for faster results. One dose of HPV vaccine now recommended for younger groups, says immunization committee National committee is maintaining its two-dose recommendation for people 21 to 26 years old. Updates to routine screenings clinicians need to know about Routine screenings in adults could get a bit easier in the future or could be delivered a different way. Here are some changes that are likely to be happening soon. Breast cancer drugs could fight prostate cancer The effectiveness of androgen-targeted treatments for prostate cancer tends to fade over time, so new strategies are urgently needed. NEW DRUG: Tecentriq SC for multiple cancer types Get the info you need on this new product, part of our drug news roundup for July. A rare voice box transplant helped a cancer patient speak again, part of a pioneering study A Massachusetts man has regained his voice after surgeons removed his cancerous larynx and, in a pioneering move, replaced it with a donated one. Researchers use AI to find subgroup of endometrial cancer linked to poor outcomes The finding will help identify patients who need more comprehensive treatment. NEW DRUG: Truqap for breast cancer Get the info you need on this new product, part of our drug news roundup for July. Doctors excited about targeted prostate cancer therapy, but can’t prescribe it yet Dale Cousins is part of a clinical trial of radioligand therapy, or RLT—a precise targeting of cancer cells with radiation given intravenously. First Previous 18 19 20 21 22 Next Last
